Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies.
about
Comparison of ceftriaxone and ampicillin plus chloramphenicol for the therapy of acute bacterial meningitisCeftriaxone therapy of serious bacterial infections in adults.Randomised comparative study of ceftriaxone and spectinomycin in gonorrhoea.Penetration of ceftriaxone into human pleural fluid.In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia modelChemistry of newer antibiotics directed toward overcoming bacterial resistanceEfficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae.Monocyclic and tricyclic analogs of quinolones: mechanism of actionPharmacokinetics of ceftriaxone in liver-transplant recipientsSingle-dose pharmacokinetics of ceftriaxone in healthy Chinese adults.Pharmacokinetics of ceftriaxone in humans.Efficacy of ceftriaxone in serious bacterial infections.Ceftriaxone: in vitro studies and clinical evaluationComparative efficacies of ceftriaxone, moxalactam, and ampicillin in experimental Salmonella typhimurium infectionIn vitro antimicrobial activity of eight new beta-lactam antibiotics against penicillin-resistant Neisseria gonorrhoeaePharmacokinetics of ceftriaxone in patients with renal failure and in those undergoing hemodialysisComparison of ceftriaxone and traditional therapy of bacterial meningitis.Ceftriaxone pharmacokinetics in patients with various degrees of renal impairmentCrossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteersFailure of beta-lactam antibiotics and marked efficacy of fluoroquinolones in treatment of murine Yersinia pseudotuberculosis infection.Ceftriaxone versus povidone iodine in preventing wound infections following biliary surgeryInfluence of growth medium on the in vitro activities of second- and third-generation cephalosporins against Streptococcus faecalisUse of third-generation cephalosporins. Enterobacteriaceae.Ceftriaxone: a beta-lactamase-stable, broad-spectrum cephalosporin with an extended half-life.Charge and lipophilicity govern the pharmacokinetics of glycopeptide antibiotics.In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporin.Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism.Comparison of ceftriaxone with cefoxitin in the treatment of penicillin-resistant gonococcal urethritis.Efficacy of a twelve-hourly ceftriaxone regimen in the treatment of serious bacterial infections.Comparison of susceptibilities of anaerobic bacteria to cefmenoxime, ceftriaxone, and other antimicrobial compounds.Characterization of the relationship between serum and milk residue disposition of ceftriaxone in lactating ewes.Comparative in vitro activity of ceftriaxone against anaerobic bacteria.Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults.In vitro and in vivo synergy between ceftriaxone and aminoglycosides against Pseudomonas aeruginosa.Ceftriaxone pharmacokinetics in elderly subjects and penetration into epididymis.Clearance of ceftriaxone in critical care patients with acute renal failure.In vitro antibacterial properties of cefetamet and in vivo activity of its orally absorbable ester derivative, cefetamet pivoxil.Ceftriaxone: in vitro activity against 410 bacterial isolates compared with cefotaxime.Interindividual variability in biliary excretion of ceftriaxone: effects on biliary lipid metabolism and on intestinal microflora.
P2860
Q30451305-247F5F60-4C79-41F3-96A9-63D69A3FF23EQ33476936-A077414E-F29B-4AF2-BB37-DA51DE00F74AQ33582685-3615ADA6-33AB-4ED5-BE72-5E21772281D7Q33739594-8082F035-F980-48C5-A418-D43EEE4504ECQ33757851-59155B5C-FAA4-45BB-A4F8-249ADA51FBA4Q35119472-B0C397CB-2AD1-439A-B714-E81B2F8E7EF3Q35130268-8DAAB772-A531-4F7A-8431-DB6E40B3DAE2Q35539022-6C9D4073-66FF-4260-A642-A0015B02E606Q35549962-30DA2459-FEB0-4B80-9CB7-17AA8946FDE6Q35569544-5A17B101-D808-4002-8246-1443B4BACE09Q35672073-346D565E-7141-4E5D-821C-6F028DB5843CQ35674264-063F7D12-D91E-4E95-9D8B-F658FFFAC090Q35712352-5D733BF8-365B-4ABC-AA1A-9A9D89F75ED8Q35715192-5F04C86A-6349-4D31-AEA4-F3CBA1E2668AQ35740391-21891C8B-68AB-4AD7-B229-CA1267294433Q35755052-42908D0B-51E9-4A5F-83C7-7187CAA4DCE5Q35756153-822A51B5-26E9-4F30-8043-20708B464D1DQ35758837-304DFB7D-2F47-4264-B993-2E2374B82493Q35767452-BAB20F58-0354-4E81-9608-A6F5C3E3CC9AQ36754819-096C6BFB-63E7-4C4B-B94C-47F89D89D72AQ36815860-ACBA4899-1B67-415D-A4F5-6DF048D01854Q37269692-40447F69-39DF-4028-95C4-18E71E44684BQ37381380-2566338D-102C-41B5-A658-3E19B433A488Q39835731-72F566FC-405D-423A-914E-5B5D45C9B59FQ39850906-8F5E2297-7849-4AC5-B71F-5A56C1FAFA53Q39855525-1AD9D50A-1BB5-4D6E-9C5F-1A0EABAECB2CQ39857019-705F768A-5D1A-4E9C-A13E-EE8119D07644Q42151536-B322B38E-7954-4E95-BF95-B7F27E15E282Q42176930-2865FD7F-BAF6-4F2F-8123-15D836B0AEDAQ42253836-029EF9CC-519B-4AB9-8704-970C93EA9C8BQ42691694-03EFCAC7-5D90-45CB-A79C-0C71C54B1CA5Q42926858-059F175D-4655-481E-AD7B-B40D6701B865Q42929968-FB53DB38-D325-41A3-BB66-3F988C59C6C8Q44632608-17A2942E-052F-440F-A220-A37E560BDCC7Q45006901-44682FEF-A988-4C48-AA82-F4D4D346F8E3Q53035501-32FA12A4-6048-4929-B699-04EF90C73ECFQ54353071-08B3F4FB-ED66-427A-A5FE-EEF98036A75EQ54513149-F9F85DC4-361B-48F1-8B86-BB1F70FE831CQ54747673-6142C5E7-7728-4CA2-AB42-E5FC9C75281D
P2860
Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies.
@en
type
label
Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies.
@en
prefLabel
Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies.
@en
P2093
P2860
P356
P1476
Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies.
@en
P2093
P2860
P304
P356
10.1128/AAC.18.6.913
P407
P577
1980-12-01T00:00:00Z